The SOFA score-development, utility and challenges of accurate assessment in clinical trials.

Lambden S, Laterre PF, Levy MM, Francois B. · 2019

Read The SOFA score-development, utility and challenges of accurate assessment in clinical trials. by Lambden S, Laterre PF, Levy MM, Francois B. (2019) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc6880479.txt.

Introduction

Lambden and co-authors review the SOFA score in Critical Care. The Sequential Organ Failure Assessment grades how badly a critically ill patient's organs are failing. It was built to describe groups of patients, and it proved valid across many settings. Uses have since multiplied. A rise of 2 points or more now helps define sepsis itself.

Regulators even accept SOFA change as a stand-in measure of whether a new sepsis drug works in early trials. That raises the stakes on scoring each patient exactly the same way. Modern care, such as high-flow nasal oxygen, postdates the score and fits it awkwardly. The authors propose clarifications so serial scores stay accurate and comparable.

Catalog record

CREATORLambden S, Laterre PF, Levy MM, Francois B.
YEAR2019
COLLECTIONPAPERS
FORMATTXT
FILE SIZE45 KB
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC6880479

Browse the full library · About the Tower of Babel

Full text

The opening of the work, from the library's hosted text:

The SOFA score—development, utility and challenges of accurate assessment in clinical trials By Simon Lambden, Pierre Francois Laterre, Mitchell M Levy, Bruno Francois Published in: Critical Care DOI: 10.1186/s13054-019-2663-7 ABSTRACT Abstract The Sequential Organ Failure Assessment or SOFA score was developed to assess the acute morbidity of critical illness at a population level and has been widely validated as a tool for this purpose across a range of healthcare settings and environments. In recent years, the SOFA score has become extensively used in a range of other applications. A change in the SOFA score of 2 or more is now a defining characteristic of the sepsis syndrome, and the European Medicines Agency has accepted that a change in the SOFA score is an acceptable surrogate marker of efficacy in exploratory trials of novel therapeutic agents in sepsis. The requirement to detect modest serial changes in a patients’ SOFA score therefore means that increased clarity on how the score should be assessed in different circumstances is required. This review explores the development of the SOFA score, its applications and the challenges associated with measurement. In addition, it proposes guidance designed to facilitate the consistent and valid assessment of the score in multicentre sepsis trials involving novel therapeutic agents or interventions. Conclusion The SOFA score is an increasingly important tool in defining both the clinical condition of the individual patient and the response to therapies in the context of clinical trials. Standardisation between different assessors in widespread centres is key to detecting response to treatment if the SOFA score is to be used as an outcome in sepsis clinical trials. Keywords: Sepsis, Sequential Organ Failure Assessment, SOFA, Clinical Trials, Surrogate endpoints, Critical Care trials, Multiple organ failure BACKGROUND The SOFA score has become integrated into a range of aspects of critical care since its development in the early 1990s, and it is now widely employed in the daily monitoring of acute morbidity in critical care units. The SOFA score was designed to provide population level insights into the acute morbidity of ICU patients; however, its application has broadened substantially in recent years. Following the development of new definitions [1–3], it is now used as a key criterion in the diagnosis of the sepsis syndrome on an individual patient level [3]. It is also increasingly used to determine the efficacy of novel therapeutic agents in phase II trials, a development that follows acceptance by the European Medicines Agency (EMA) and others of organ dysfunction scores as an endpoint in exploratory trials for sepsis [4]. This review describes the development of the score and the challenges associated with robust and reproducible calculation and proposes guidance for its assessment in clinical trials, where inconsistency in SOFA score measurement could introduce substantial variability in key outcomes. The development of the SOFA score The SOFA (Sequential Organ Failure Assessment) score was developed following a consensus meeting in 1994, the stated aim of which was to create a score ‘to describe quantitively and as objectively as possible the degree of organ dysfunction/failure over time in groups of patients or even individual patients’ [5]. The score was designed to describe a sequence of complications of critical illness and not to predict outcome, although the authors acknowledged that any functional morbidity score must also be associated with mortality. Initially described as the sepsis-related organ failure assessment, the utility of the score for the assessment of acute morbidity in a range of critical illnesses was recognised early and the title changed. SOFA was based on six different scores, one for each of the respiratory, cardiovascular, hepatic, coagulation, renal and neurological systems each scored from 0 to 4 with an increasing score reflecting worsening organ dysfunction [5, 6]. The development team showed retrospectively that the score detected differences in severity of illness [5] and proposed its use as an alternative to other assessments of multiple organ dysfunction that had been developed in the early 1990s [7]. Following its initial validation, prospective analysis of the score’s utility was undertaken in 16 countries [6]. The study showed that some sub-scores and also the total score were associated with survival. Moreno et al. [8] studied the impact of maximum SOFA score in the same population and showed that there was a good correlation between increasing score and mortality. The score performed well as a discriminator of survival status at ICU discharge. In addition to studying the maximum SOFA score, the change in score, or delta SOFA (total maximum SOFA score minus admission total SOFA score) also demonstrated a strong correlation with ICU mortality. Further prospective evaluations in differing settings have validated the SOFA score, its maximum value during ICU stay and also change in SOFA over time as valid tools for the assessment of morbidity in critical illness [9–12], and the score has become a common feature of observational study reporting. Calculation of the SOFA score standard approach SOFA score may traditionally be calculated on admission to ICU and at each 24-h period that follows. The tool employs six criteria reflecting the function of an organ system (respiratory, cardiovascular, renal, neurological, hepatic and haematological) and allocates a score of 0–4 as described below in Table 1. [Table: The criteria for assessment of the Sequential Organ Failure Assessment (SOFA) score] In cases where the physiological parameters do not match any row, zero points are given. In cases where the physiological parameters match more than one row, the row representing the highest score is selected. SOFA score terminology The SOFA score has been applied in a range of applications with some variation in the terminology employed. A number of terms are commonly used and are associated with the following definitions: - Admission SOFA: The admission SOFA score is calculated based on the most severe value for each sub-score in the 24 h preceding admission to ICU [9]. - Daily Maximum SOFA score: The daily maximum SOFA score is equivalent to the daily SOFA score as when calculated for each 24 h assessment; the most severe value of each sub-score for that time period should be calculated in the assessment of the SOFA score. - Maximum SOFA score: The maximum SOFA score describes the highest daily SOFA score over the course of the study period. - Delta SOFA score: The delta SOFA is calculated as the change in total SOFA score (or that of an individual sub-score) between a defined time point and the baseline value. The baseline value may be the admission SOFA or a defined study day. - Mean SOFA: The mean SOFA score is calculated for an individual patient over the course of a defined study period based on the total SOFA score for each study day. Generic rules for measuring components of the SOFA score A number of standard rules have been proposed for the calculation of SOFA score values [9] . Selecting the daily value The value for each sub-score that represents the most severe (worst) value for the respective 24-h period for each parameter was used in initial validation and subsequent clinical studies using the SOFA score. Proposal 1 SOFA score should be undertaken prior to the start of any intervention or admission and for each subsequent 24-h period. At each assessment,

Read the complete text